Phase 2 Study of Oral IXAZOMIB in Adult Participants With Relapsed and/or Refractory Follicular Lymphoma
Condition(s):Follicular LymphomaLast Updated:October 29, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Follicular LymphomaLast Updated:October 29, 2019Completed
Condition(s):Multiple MyelomaLast Updated:August 13, 2013Terminated
Condition(s):Acute Graft Versus Host DiseaseLast Updated:October 10, 2023Recruiting
Condition(s):Hodgkin LymphomaLast Updated:December 19, 2023Recruiting
Condition(s):Colorectal Cancer, MetastaticLast Updated:July 19, 2023Terminated
Condition(s):Peripheral T-Cell LymphomaLast Updated:June 14, 2016Completed
Condition(s):Acute GVH DiseaseLast Updated:November 16, 2022Active, not recruiting
Condition(s):Non-Hodgkin LymphomaLast Updated:May 26, 2023Completed
Condition(s):BRAF V600E-mutant Metastatic Colorectal CancerLast Updated:February 2, 2024Completed
Condition(s):Acute Myeloid Leukemia, Adult; AML; AML, AdultLast Updated:September 22, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.